elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35050195-8F76BA08-AD15-4E85-A646-71F50E518420
Q35050195-8F76BA08-AD15-4E85-A646-71F50E518420
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-8F76BA08-AD15-4E85-A646-71F50E518420
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
P50
Q35050195-8F76BA08-AD15-4E85-A646-71F50E518420
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-8F76BA08-AD15-4E85-A646-71F50E518420
rank
NormalRank
type
BestRank
Statement
P1545
1
http://www.w3.org/2001/XMLSchema#string
P1932
Josep Tabernero
http://www.w3.org/2001/XMLSchema#string
P50
Josep Tabernero